Genotypic variation of HIV-1 reverse transcriptase and protease: Comparative analysis of clade C and clade B

AIDS

Volumn 15, Issue 12, 2001, Pages 1453-1460

  Grossman, Zehava ^a,h   Vardinon, Nurit ^b   Chemtob, Daniel ^c   Alkan, Michael L ^d   Bentwich, Zvi ^e   Burke, Michael ^b   Gottesman, Giora ^f   Istomin, Valery ^g   Levi, Itzchak ^h   Maayan, Shlomo ⁱ   Shahar, Eduardo ^j   Schapiro, Jonathan M ^k  

^a Public Health Laboratories   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c MINISTRY OF HEALTH   (Israel)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^e HEBREW UNIVERSITY   (Israel)

^f MEIR MEDICAL CENTER   (Israel)

^g HILLEL YAFFE MEDICAL CENTER   (Israel)

^h SHEBA MEDICAL CENTER   (Israel)

ⁱ HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^j RAMBAM MEDICAL CENTER   (Israel)

^k Sheba Medical Center ^*

more..

Author keywords

Clade C; Genotyping; HIV 1; Mutations; Protease; Resistance; Reverse transcriptase

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; PROTEINASE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ADULT; ARTICLE; CONSENSUS SEQUENCE; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME STRUCTURE; ENZYME SUBUNIT; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; ISRAEL; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; VIRUS MORPHOLOGY; VIRUS RESISTANCE;

ADOLESCENT; ADULT; AGED; ANTI-HIV AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; FEMALE; GENOTYPE; HIV INFECTIONS; HIV PROTEASE; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE INHIBITORS; VARIATION (GENETICS);

EID: 0035902902     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200108170-00001     Document Type: Article

References (23)

1. Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G
2. First full length sequence prototypes of HIV-1 clades C, E and G: Two of three are mosaic genomes
3. Expression and characterization of HIV type 1 envelope protein associated with a broadly reactive neutralizing antibody response
4. Genetic analysis of HIV-1 strains and an interesting model of vaccine development for an African region with high incidence of HIV-1 infections
5. pol gene diversity of five human immunodeficiency virus type 1 subtypes: Evidence for naturally occurring mutations that contribute to drug resistance, limited recombination patterns, and common ancestry for subtypes B and D
6. The role of genotypic resistance testing in selecting therapy for HIV
7. Antiretroviral drug resistance testing in adult HIV-1 infection: Recommendations of an International AIDS Society-USA Panel
8. Molecular epidemiology of HIV in Israel
9. HIV incidence in Ethiopian immigrants to Israel
10. Epidemiological and immunological study of HIV-seropositive Ethiopian immigrants in Israel
11. Epidemiological and serological studies in HIV-infected Ethiopian immigrants to Israel
12. The epidemiology of adult AIDS and HIV infection in Israel
13. African HIV-1 subtype C and rate of progression among Ethiopian immigrants in Israel
14. Adult and adolescent HIV infection in Israel 1980-1998
15. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors
16. Serotyping of HIV type 1 infections: Definition, relationship to viral genetic subtypes, and assay avaluation
17. Human immunodeficiency virus reverse transcriptase and protease sequence database: An expanded data model integrating natural language text and sequence analysis programs
18. Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor
19. Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use
20. Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy
21. Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors
22. The prevalence of HIV-1 resistance associated mutations in a large ARV-naive European population. A baseline analysis of the SERVICE project